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Summary 
Deep sequencing of mammalian DNA methylomes has uncovered a previously unpredicted 
number of discrete hypomethylated regions in intergenic space (iHMRs). Here, we combined 
whole genome bisulfite sequencing data with extensive gene-expression and chromatin-state 
data to define functional classes of iHMRs, and to reconstruct the dynamics of their 
establishment in a developmental setting. Comparing HMR profiles in embryonic stem and 
primary blood cells, we show that iHMRs mark an exclusive subset of active DNase 
hypersensitive sites (DHS), and that both developmentally constitutive and cell-type specific 
iHMRs display chromatin states typical of distinct regulatory elements. We also observe that 
iHMR changes are more predictive of nearby gene activity than the promoter HMR itself, and 
that expression of non-coding RNAs within the iHMR accompanies full activation and complete 
demethylation of mature B cell enhancers. Conserved sequence features corresponding to 
iHMR transcript start sites, including a discernable TATAA motif, suggest a conserved, 
functional role for transcription in these regions. Similarly, we explored both primate-specific and 
human-population variation at iHMRs, finding that while enhancer iHMRs are more variable in 
sequence and methylation status than any other functional class, conservation of the TATA box 
is highly predictive of iHMR maintenance, reflecting the impact of sequence plasticity and 
transcriptional signals on iHMR establishment. Overall, our analysis allowed us to construct a 3-
step timeline in which 1) intergenic DHS are pre-established in the stem cell, 2) partial 
demethylation of blood specific intergenic DHSs occurs in blood progenitors, and 3) complete 
iHMR formation and transcription coincide with enhancer activation in lymphoid-specified cells.  
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Introduction 
 
Until recently, our knowledge of genome function has been focused on protein-coding genes. 
Yet, analyses of evolutionary constraint across vertebrates and eutherian mammals reveal 
millions of bases in the human genome that have undergone purifying selection, of which only a 
fraction are within known protein-coding sequences (Birney et al. 2007). Many (~40%) are 
bundled into conserved units as small as tens of nucleotides that are scattered across vast 
intergenic space (Lindblad-Toh et al. 2011). Interestingly, most of these do not coincide with 
sequence features characteristic of protein-coding or structural elements, but instead, suggest a 
regulatory function, based for example on an enrichment of transcription factor binding motifs 
(TFBS).  
 
Combined profiles of modified histones and DNase accessibility have charted chromatin states 
across diverse cell types from fly (Kharchenko et al. 2011), human (Ernst et al. 2011), and 
mouse (Shen et al. 2012). These have exposed numerous putative cis-regulatory elements, 
most notably enhancers and insulators. The activity of such elements is frequently specific to 
cell-type and context and therefore a synthesis of developmentally diverse, tissue-specific 
genomic datasets is required to detect and interpret regulatory function. 
 
Enhancers, and other distal cis-regulatory elements are transcription factor (TF) docking sites 
for long-distance gene regulation. They help to establish alternate gene expression programs 
that in turn guide cell fate decisions and control cellular phenotypes (Bulger and Groudine 
2011). For many TFs, stable occupancy at target sites relies on a DNA sequence free of 
cytosine methylation and nucleosome interference. Further, recent studies addressing single-
receptor models propose significant interplay between DNA methylation, transcription factor 
binding and the activity of enhancers (Stadler et al. 2011, Wiench et al. 2011). 
 
DNA methylation itself is thought to be a critical component of the mechanisms that define and 
stabilize cell-type identity and developmental state. In a typical mammalian genome, 
methylation is the default state, with 70-80% of all CpG sites modified.  Unmethylated CpGs 
frequently occur in areas of high CpG density, so called CpG Islands (CGIs), which often 
overlap gene promoters. Recently, we described an unbiased, empirical model for detecting 
hypomethylated regions (HMRs), based on clustering of largely unmethylated  CpG sites in the 
genome (Molaro et al. 2011), independent of pre-defined CGIs. Using this approach, we 
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identified a new class of intergenic HMRs (iHMRs) that differ in several ways from those 
observed near promoters, including size and sequence composition. With few specific 
exceptions, promoter HMRs (pHMRs), whether coinciding with CGIs or not, are shared 
(constitutive) across diverse cell-types. For this reason, their presence does not specifically flag 
genes that are transcriptionally active (Hodges et al. 2011). In contrast, many iHMRs tend to be 
either stem cell specific or “de novo” demethylated in specific differentiated cells. Thus, we 
sought to understand the role of hypomethylation at these sites in relation to different regulatory 
activities. In particular we asked whether iHMRs designate select classes of regulatory 
elements, and if their component features are prognostic of gene activity.  
 
Here, we show that differential comparisons of HMR profiles across multiple cell types can 
provide detailed information about the presence and status of regulatory elements in individual 
cell types. Using HMR profiles obtained from bisulfite sequencing (BS-seq) of 5 different human 
and 3 chimpanzee cell-types, we defined sets of constitutive and cell-type specific iHMRs. The 
cells represented both embryonic (H1ESC) (Lister et al. 2009) and adult somatic stem cell 
stages (hematopoietic stem and progenitor cells, HSPCs), in addition to differentiated states 
from two divergent hematopoietic lineages (B lymphocytes, the GM12878 lymphoblastoid cell 
line, and neutrophils) (Hodges et al. 2011). We superimposed the HMR profiles on available 
ChIP-seq and DNase-seq datasets from ENCODE (The ENCODE Project Consortium 2012), 
finding a remarkably precise, highly cell-type specific overlap between HMR calls and modified 
histone peaks. This enabled us to clearly distinguish enhancer-, insulator-, and promoter-like 
iHMRs, and their respective methylation dynamics during differentiation from stem to mature 
cells. Furthermore, using CAGE and RNA-seq datasets from ENCODE, we find a strong 
connection between the methylation status of iHMRs and transcription of non-coding RNAs at 
the intergenic site. We show that transcription at iHMRs originates from defined sequence 
elements, and gives rise to distinct classes of RNAs that reflect the iHMR’s regulatory activity. 
Next, we compared the human methylation profiles with data corresponding to orthologous 
blood cell types from chimpanzee. Methylation states at HMRs are generally conserved 
between human and chimp, with variation depending on the HMR type and divergence of the 
underlying sequence elements. Overall, enhancer iHMRs are the most variable between 
species, individuals, and developmental states. Our data indicate that progressive 
demethylation and transcription together define the most active enhancer elements in mature 
cells. Thus, HMRs reveal accurate cues to the activity of regulatory elements and RNA 
polymerase genome-wide, providing a strong framework to analyze methylation changes during 
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development. Our integrated analysis of HMRs, and in particular iHMRs, can therefore 
determine cell-type specific regulatory centers, including signatures of differentiation.  
 
Results 
 
Recently, using genome-wide DNA methylation datasets we have shown that intergenic 
domains of hypomethylation (HMRs) are more widespread and more variable during cellular 
differentiation than had been previously appreciated (Hodges et al. 2011). In fact, HMRs occur 
throughout the genome, differing in their sequence context (e.g. CpG density) and their dynamic 
behavior during development. Because of this, HMRs, unlike CGIs, cannot be predicted by 
sequence characteristics alone and must instead be identified empirically using cell-type 
specific methylation datasets. Here, using whole genome BS-seq data, we compared sets of 
HMRs in H1ESCs and primary human B cells. Differential HMR analysis revealed three broad 
categories of sites with different features: (1) shared, (2) specific or (3) shared and significantly 
expanded in length in one cell-type (Figure 1A, S1A-D). These broad classifications alone 
permit some initial inferences regarding the potential behavior of the HMR. For example, HMRs 
overlapping gene promoters (“pHMRs”) have high CpG density and are predominantly shared 
between the two cell types (shared or both shared and expanding in one cell-type relative to the 
other). Most intergenic and intronic HMRs (iHMRs), on the other hand, have lower CpG density 
than canonical CGIs (Figure S1A-D) and are often cell-type specific. The exceptions are CTCF-
bound iHMRs, which are predominantly shared between the cell-types. Examples of a shared, 
expanding pHMR and an intergenic iHMR for two B cell associated loci are shown in Figure S2. 
 
Overall, the number of cell-type specific iHMRs is 4-fold higher in mature cells (5,106 in H1 ESC 
vs 20,556 in B-cells), indicating that lineage specific loss of methylation at intergenic sites 
occurs during differentiation. We have previously found an enrichment for binding motifs of 
lymphoid-specific TFs at B cell iHMRs (Hodges et al. 2011). In addition, recent work has shown 
that binding of some transcription factors is directly linked to intergenic hypomethylation (Stadler 
et al. 2011). Therefore, we hypothesized that these iHMRs designate a lymphoid lineage-
specific class of distal regulatory elements. 
 
iHMRs discriminate a class of highly active, conserved DNase hypersensitive sites  
DNase I hypersensitivity sequencing (DNase-seq) is the established method for determining 
chromatin accessibility genome-wide and hence for identifying putative regulatory elements. 
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Since a correlation between DNase sensitivity and methylation levels at some CpG sites has 
been reported (Thurman et al. 2012), we investigated the relationship between iHMRs and 
intergenic DNase hypersensitivity sites (DHS) in H1ES cells and the GM12878 lymphoblastoid 
cell line (LCL, using data from LCLs as a proxy for primary B cells; See Methods and Figure 
S8). A majority of iHMRs overlaps significant DHS peaks in mature and stem cells (57% and 
84%, respectively; Figure 1B), and at least weak DHS signal enrichment can be detected in 
almost all iHMRs (Figure 1C). In contrast, DHSs far out number iHMRs and only some (11-33%) 
DHSs were hypomethylated (Figure 1B, S6A). CpG density is a strong predictor for the 
methylation state of a DHS, with low CpG density correlating with high methylation levels 
(Figure 1D; Spearmen r = -0.17; p = 1.6e-133). On the other hand, DHSs with higher CpG 
density show bimodal methylation levels. Among these high CpG sites, hypomethylation occurs 
specifically at those DHS positive for CTCF binding (68% vs. 31% without CTCF; p = 3.6e-185, 
Fisher-test) or histone modifications, such as H3K4me2, associated with active regulatory states 
(Figure 1E). Hypomethylated DHSs also show on average higher sequence conservation than 
those that do not overlap HMRs (Figure 1F; p = 2.5e-229; Wilcoxon-test).  
 
Using MNase-seq data from LCLs, we observed nucleosome-depleted regions matching the 
length of the iHMRs (Figure S1E).  This depletion is dynamic and cell-type specific as H1ESC-
specific iHMR sites are not depleted for nucleosomes in LCLs. Together, these data suggest 
that a specific subset of important DHSs are de-novo demethylated during lymphoid lineage-
specification, and that loss of methylation is associated with local changes to nucleosomes. 
 
Composite features of HMRs reflect a diversity of regulatory states. 
To investigate what classes of genomic elements give rise to iHMRs and their potentially 
diverse regulatory functions, we relied on ChIP-seq against modified histones, DNase-seq and 
related techniques, to classify iHMRs based on their chromatin signature (Heintzman et al. 
2007). We gathered an extensive catalog of chromatin state datasets from the ENCODE project 
(The ENCODE Project Consortium 2012) in H1ESC and LCLs. Globally, we defined 4 major 
classes of iHMRs in H1ES cells, based on different combinations of CTCF occupancy, DNase 
hypersensitivity, Pol2 binding, and histone modifications (Figure 2A). Their respective chromatin 
states resembled the typical signatures of insulators (“CTCF”), enhancers (“Enhancer-like”), 
active promoters (“Promoter-like”), and bivalent elements (“Bivalent”) (Ernst et al. 2011). This 
classification was further supported by a specific enrichment of ENCODE enhancer and 
promoter-predictions (Yip et al. 2012) in their respective iHMR groups (Figure S1D, p < 1.6e-
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110; Fisher-test). iHMRs overlapping sequence-defined CpG islands (outside of annotated 
gene-promoter regions) are mostly shared between cell-types (97% compared to 68% for non-
CGI iHMRs; p < 2.2e-16; Fisher-test). In H1ESCs, CGI-overlapping iHMRs were found to be 
either Promoter-like, with levels of H3K4me3 and pol2 binding reminiscent of pHMRs at 
annotated genes, or in the bivalent state, with high levels of H3K4me2 and H3K27me3. 
Enhancer-like iHMRs, on the other hand, are mostly cell-type specific and lie outside of 
annotated CGIs (Figure 2A). This classification strategy could also be applied to other cell-
types. In LCLs, a less prominent class of bivalent iHMRs was present, and instead we observed 
a large group of “silent” iHMRs marked by H3K27me3, with little or no H3K4-methylation and 
lower DNase hypersensitivity (Figure S1F).  A second class of “promoter-like” iHMRs in a 
putatively ‘inactive’ state (no H3K27ac and RNA Pol II) was also observed. As predicted, B cell 
specific iHMRs (especially in the ‘enhancer’ class), show highly cell-type specific chromatin 
states, while shared iHMRs (mostly in the ‘CTCF’ and ‘promoter’ classes) also share many 
histone marks between cell-types (Figure S1F). 
 
Meta-profiles of chromatin states confirmed distinct patterns of histone modifications specifically 
within the region identified by hypomethylation at all iHMR types (Figure 2B). In all cases 
H3K4me2 covers the entire hypomethylated region, along with a central narrower peak of 
DNase hypersensitivity. H3K4me1 enrichment corresponds with the boundaries of enhancer 
and promoter-like iHMRs, while promoter-like iHMRs also contain a central, sharp peak of 
H3K4me3. By contrast, the bivalent iHMRs lie within broader domains of H3K27me3, where 
H3K4 methylation specifically marks the core hypomethylated region. The functional 
significance of these iHMR classifications is supported by enrichments for pluripotency factors 
at stem cell enhancers (POU5F1 and NANOG) and polycomb proteins (SUZ12) at bivalent sites 
(Figure 2C). Histone acetyltransferase EP300, like RNA polymerase II, is abundant at both 
enhancer and promoter-like iHMRs, but not present at transcriptionally silent CTCF and bivalent 
sites.  Overall different types of iHMRs identify regions displaying different chromatin states, 
suggesting a diversity of regulatory activities associated with hypomethylation in specific 
developmental contexts. 
 
Coordinated changes at iHMRs and nearby pHMRs can impact the activities of 
associated genes. 
Because CpG dense gene promoter HMRs are typically pre-established in embryonic stem cells 
and shared between different cell-types, tissue specific activation of genes is often difficult to 
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predict from the methylation states of their promoters. Previously, we showed that pHMRs 
expand upon lineage-specific gene activation during adult blood cell maturation. Illustrating this 
pattern, differential H1ESC and B cell methylation shows asymmetric spreading of 
hypomethylation at pHMRs outside of the constitutive CpG-rich core region (Figure 3A, S3A, 
S3B). The direction and extent of differential hypomethylation differs greatly between genes, but 
in each case tracks very closely with cell-type specific spreading of H3K4me2 at these 
promoters (Figure 3B, S3C).   
 
Given that most differential methylation occurs distal to gene promoters and that many of these 
regions show features of regulatory elements, we asked whether iHMRs are informative about 
the regulation of nearby genes.  First, we observed that expanding pHMRs are more proximal to 
cell-type specific iHMRs (p = 2.2e-17; Wilcoxon-test), but not to CTCF iHMRs (p = 0.77; 
Wilcoxon-test) (Figure 3C). This suggested that demethylation of enhancers might be involved 
in the activation of these genes. Indeed, both enhancer iHMR hypomethylation and promoter 
pHMR expansion together are more predictive of higher gene expression changes than either 
on its own. 44% of genes with an expanded promoter HMR and a nearby (< 25kb) iHMR show 
elevated expression (fold change > 2), compared to 23% with an expanded pHMR, but no 
nearby (>100kb) iHMR and 12% without a significant expansion of the pHMR, but an iHMR 
closer than 25kb. This effect is diluted with iHMR distance from the gene (Spearman r = -0.21; p 
= 2.93e-125) (Figure 3D).  
 
Breaking this overall pattern, in H1ES cells a subset of expanded pHMRs occurs at silent genes 
(Figure 3E, S3D; p = 2.6e-26; Wilcoxon-test). In those cases, high levels of H3K27me3 cover 
the pHMR, spreading along the expanded pHMR region, while H3K4me2 remains confined to 
only the constitutively hypomethylated core region (Figure S3E). Consistently, many of these 
bivalent pHMRs co-occur with nearby bivalent iHMRs (Figure 3F), as defined in Figure 1. In B 
cells, the majority of bivalent iHMRs observed in H1ESCs remains hypomethylated and are 
generally resolved into either an active (high H3K4 methylation and pol2 binding) or a silent 
(some H3K27me3 enrichment and low H3K4 methylation) chromatin state (Figure 4A, for 
examples see Figure S4). While silencing mostly occurs with H3K27 methylation, a smaller 
subset of H1 bivalent iHMRs are silenced by DNA methylation in B cells. These sites are 
completely devoid of DNase hypersensitivity and all the studied histone modifications. These 
described changes all tend to be coordinated between the iHMR and an associated pHMR. 
Illustrating these patterns, Figure 4B depicts examples of multiple shared and specific iHMRs 
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near the Annexin A2 receptor gene ANXA2R, including a cluster of bivalent H1ESC iHMRs, that 
become active in LCLs, as indicated by exchange of trimethylated H3K27 for acetylated H3K27. 
 
Transcribed, cell-type specific iHMRs mark likely active enhancers 
Many fully methylated regions in H1ESCs lost DNA methylation in the mature B cell, and we 
referred to these as de novo demethylated iHMRs. We sought to understand the timing of these 
changes during cell-fate specification, so we compared the methylation levels in B cells at these 
iHMRs with other human primary hematopoietic cell-types, including hematopoietic stem and 
progenitor cells (HSPCs) and a non-lymphoid blood cell (neutrophils) (Figure S5A). iHMRs 
shared between B cells and H1ESCs also show equally low methylation levels in the other 
blood cell-types. iHMRs not present in H1ESCs, however, show a large population of lineage-
shared sites, which have equally low methylation levels in all three blood cell-types, as well as, 
a smaller fraction of B cell iHMRs only partially hypomethylated in the other blood cells. As 
expected, these iHMRs are enriched for lymphoid specific TFs such as NFKB, ELF1, EGR1, 
EBF1 and PAX5 (data not shown) and are proximal to genes involved in lymphocyte 
development (using GREAT,(McLean et al. 2010)).  
 
In accordance with previous observations in HSPCs (Hodges et al. 2011), this suggested that B 
cell specific regulatory elements become partially hypomethylated early during hematopoietic 
differentiation and maintain this intermediate methylation state in blood sister lineages, while 
undergoing additional hypomethylation specifically in B cells. Consistent with this, the ‘silent’ 
class of demethylated B cell iHMRs (Figure S1E) is potentially active in other blood cells. These 
lymphoid specific iHMRs often are already DNase hypersensitive in stem cells, but not yet 
hypomethylated, i.e. they are shared DHSs with differential HMRs between H1ESC and B Cells 
(Figure S6B). This potentially primed state in the stem cell population is characterized by 
intermediate DNase hypersensitivity, but an almost complete absence of the studied histone 
marks, except for a slight H3K4me1 enrichment (Figure S6C). In the blood lineage, these sites 
become partially hypomethylated, while in B cells a subset acquires the signature of potentially 
active regulatory elements and is fully hypomethylated. The rest remain “silent” in B cells,  
showing H3K27me3 enrichment.  
 
To better understand these progressive methylation changes between cell-types, we searched 
for associated regulatory events. We observed that some de novo iHMRs showed evidence of 
being transcribed (see example in Figure 4B). Transcription at some enhancers sites has 
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recently been described as a marker of an active enhancer state (so called eRNA) (Kim et al. 
2010), which prompted us to investigate whether intergenic transcription was linked more 
generally to cell-type specific iHMR hypomethylation. We indeed found that transcriptional 
activity is not an exclusive property of pHMRs at gene promoters or ‘promoter-like’ iHMRs. In 
H1ESCs, over 44% of intergenic enhancer-like iHMRs possess CAGE tags, which represent the 
transcription start site (TSS) of capped transcripts. In LCLs, transcription occurs at those iHMRs 
with the most B cell specific hypomethylation (Figure 4C; p = 7.4e-35; Wilcoxon-test). 
Compared to the other lineage-shared iHMRs, B cell specific transcribed intergenic HMRs also 
display higher levels of several histone modifications, particularly H3K27ac (p = 1.8e-293; 
Wilcoxon-test) suggesting a strong enrichment for active lymphoid enhancers (Figure 4D) 
(Creyghton et al. 2010). Similarly, among iHMRs, which were bivalent in H1ESCs, transcription 
in LCLs marks those regions that lose H3K27me3 (Figure S5B).  Importantly, this iHMR 
transcriptional activation is correlated with the activation of nearby genes (Figure S5C-D). 
Together these data suggest that iHMR transcription is linked to highly cell-type specific 
demethylation of previously primed loci, which may function as cell-type specific active 
enhancer elements (see Figure 7 and Discussion).  
 
Features of transcription at iHMRs reveal positional cues in the primary sequence 
We analyzed RNA-seq datasets (Djebali et al. 2012) to further explore the nature of 
transcription at iHMRs. Consistent with our functional classification scheme, different classes of 
iHMRs generate distinct types of RNA transcripts (with the exception of the mostly silent CTCF 
iHMRs) (Figure 5A-C). All transcripts are less abundant overall than annotated long non-coding 
RNAs and mRNAs. Capped transcripts from bivalent iHMRs and enhancer iHMRs are even less 
frequent in the steady state RNA population than transcripts derived from promoter-like iHMRs 
(Figure 5A; p = 2.6e-10; Wilcoxon-test). Bivalent iHMRs are enriched for polyadenylated 
transcripts at levels comparable to annotated transcripts, while RNAs from enhancer-like iHMRs 
are mostly, but not exclusively, nuclear and non-poly-A+ compared to RNAs from promoter-like 
iHMRs (p = 7.2e-6; Wilcoxon-test, Figure 5B,C), consistent with previous descriptions of eRNA 
(Kim et al. 2010). The distinction between enhancer-like and promoter-like transcribed iHMRs is 
also reflected in their primary genomic sequence. ARTS, a sequence-based promoter prediction 
tool (Sonnenburg et al. 2006), which was trained on annotated gene-promoters, assigns 
significantly lower promoter scores to enhancer-like iHMRs than promoter-like iHMRs (Figure 
5D; p = 1.3e-262; Wilcoxon-test).  
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To study the relationship between transcription and iHMR features in more detail, we used 
peaks of CAGE tags to define transcription start sites of capped RNAs within enhancer-like 
intergenic HMRs. Meta-profiles of RNA and histone data depicted well-defined start sites for 
these transcripts (Figure 5E), with CAGE tags, marking the 5’ end of the RNAs, preferentially 
situated at the center of the iHMR, and RNA-seq coverage, marking the transcript bodies, 
following the direction of transcription. 
 
This raised the question of whether specific DNA elements signal the action of RNA 
polymerases inside iHMRs. To answer this, we searched for features that coincided with the 
observed TSS positions. Histone modifications reveal a clear positional signal, with peaks of 
H3K4me1, H3K27ac and DNase hypersensitivity centered slightly upstream of the TSS (Figure 
5F). Similarly, TATA box binding protein (TBP) and TBP associated factors (TAF) are enriched 
at these loci, peaking immediately upstream of the TSS (Figure S7A) together with RNA pol II. 
Given the well-defined start sites, we looked for the TATA box sequence motif within enhancer-
like iHMRs. The TATA box is an ancient motif, which provides a precise positional cue for 
initiation by RNA pol II at a fixed distance from the TSS (Lenhard et al. 2012).  We found 
enrichment for TATA matches in transcribed enhancer-like iHMRs (Figure 5K, S7B). These 
matches occur around 20bp upstream of the eRNA TSS and show evidence of increased 
evolutionary conservation at these positions (Figure S7C-D).  
 
Interestingly, the distribution of guanines and cytosines is asymmetric around these TSSs 
(Figure 5G). This GC skew begins slightly upstream of the CAGE peak and is co-directional with 
transcription. GC skew allows the formation of thermodynamically stable R-loop structures, and 
may protect the DNA sequence from methylation (Ginno et al. 2012). This was an unexpected 
property of enhancer iHMRs, which has previously only been associated with constitutively 
hypomethylated promoter CGIs rather than with iHMRs that are comparatively CpG poor and 
dynamically demethylated during differentiation.  
 
Despite overall DNA sequence-based promoter prediction scores being low at enhancer-like 
iHMRs (Figure 5D), a distinct peak at the TSS position is seen, which further supports the notion 
that well-defined sequence features control iHMR transcription (Figure 5H). The specific TSSs, 
corresponding to chromatin and conserved sequence features, suggests a link between 
transcription and the regulatory function of at least some iHMRs, rather than iHMR transcription 
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being a purely random by-product of proximity to high concentrations of RNA pol II at the 
promoters of regulated genes. 
 
A close link between intergenic transcription and iHMR establishment is also supported by the 
observation that DHSs with CAGE tags are significantly more likely to be hypomethylated 
(Figure 5I; p = 9.8e-144 Fisher-test). Furthermore, the presence of a TATA box motif in the DNA 
sequence of a DHS is predictive of hypomethylation (Figure 5J; p = 5.2e-20; Fisher-test). 
Interestingly, among the classes of iHMRs defined in Figure 1, the TATA box distinguishes the 
cell-type specific subclass of enhancer iHMRs that are transcribed (Figure 5K). This suggests 
that recruitment of TBP (Figure S6D), RNA pol II and transcription are not purely a consequence 
of hypomethylation, but instead are directed by sequence features, that possibly play a causal 
role in the establishment of hypomethylation at these sites. 
 
Cross-Species and Within Species Comparison of iHMRs reveals evolving set of putative 
enhancers 
Comparative HMR and chromatin state analysis between cell-types revealed distinct classes of 
intergenic elements. To test for functional conservation of these iHMRs, we investigated the 
concordance of methylation states between corresponding blood cell types in chimpanzee and 
human. In adult blood cells, 77% of human shared iHMRs also overlap iHMRs in chimpanzee 
(Figure 6A). A subset of B cell-specific human iHMRs is also specifically hypomethylated in 
chimp B cells, but not other blood cell-types (p = 7.2e-287; chi squared test). Human-specific 
iHMRs show lower sequence conservation than those shared with chimp (p = 2.3e-248; 
Wilcoxon-test) (Figure 6B), suggesting that species-differential iHMRs may be explained in part 
by divergence of functional regulatory sequences. Next, for each class of human B cell iHMRs 
(defined in Figure S1E), we measured the methylation state in chimp. Notably, the methylation 
state of enhancer-like iHMRs is significantly less conserved in chimp compared to other classes 
(Figure 6C; p < 1.3e-150, Fisher-test). At human transcribed iHMRs containing a TATA box, 
conservation of the TATA motif predicts conservation of hypomethylation in chimp, (Figure 6D; 
p=0.004, Fisher-test), consistent with a role for transcriptional signals in establishment and 
maintenance of iHMRs. Consistently, this effect is not seen at CTCF iHMRs, which are for the 
most part transcriptionally inert. 
 
Since a substantial fraction of cell-type specific iHMRs showed variability between species, we 
investigated whether iHMR methylation levels might also be variable in human populations. 
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Using targeted BS-seq data from whole blood of 44 human individuals (Plongthongkum et al., 
manuscript submitted), methylation levels at individual CpG sites within HMRs were assessed. 
Variable CpGs, (i.e. sites with variation in methylation levels between individuals, not caused by 
a SNP disrupting the CpG site itself) are enriched specifically within B cell specific enhancer-like 
iHMRs compared to pHMRs or other classes of iHMRs (Figure 6E; p < 1.5e-9; Wilcoxon-test). 
Notably, iHMRs conserved with chimp also show reduced methylation variation among human 
individuals (Figure 6F; p = 1.1e-7; Wilcoxon-test), suggesting more robust hypomethylation and 
possibly stronger selective constraint on the methylation state. Together, these data show that 
intergenic loci, specifically putative enhancers, with methylation states that dynamically change 
during differentiation are also the most likely to vary both between individuals and between 
species.  
 
Discussion 
Patterns of DNA methylation, and specifically localized hypomethylation, distinguish 
developmental lineages and the different cell-types within them (Bock et al. 2012, Hodges et al. 
2011). However, we, and others, have shown that the degree of differential methylation between 
cell-types is modest among CpG dense promoters (Bock et al. 2012, Stadler et al. 2011). 
Instead the most cell-type discriminatory patterns are found in intergenic space, especially 
outside of CpG Islands. These cell-type specific iHMRs cannot be predicted by simple sequence 
characteristics and must instead be identified empirically using cell-type specific methylation 
profiles. The importance of this unbiased approach to identify functional regulatory elements has 
recently been confirmed by comparative methylation analysis across vertebrates (Long et al. 
2013). 
 
The extensive sampling of regions with lower CpG density is necessary to capture the diversity 
of putative, cell-type specific regulatory elements that might be impacted by DNA methylation. 
Here, the integration of numerous genome-scale datasets revealed that HMRs fall into distinct 
functional groups with differing methylation dynamics and regulatory behaviors during 
development. From this analysis, four dominant classes of intergenic hypomethylated regions 
emerged: enhancer-like, promoter-like, bivalent, and insulator, related to chromatin patterns 
found genome-wide (Ernst et al. 2011). However, it bears mention that sub-structure is apparent 
within each category. This is because each group displays a range of enrichment for distinctive 
histone marks and other features, resulting in somewhat diffuse cut-offs between clusters and 
revealing the complexity within groups to be even higher than depicted. This complexity of 
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regulatory elements in the non-coding genome has only recently become visible, and the link 
between DNA methylation and the diverse element-types and chromatin states has not 
previously been deeply addressed on a genome-wide scale.  
 
Our analyses investigated a number of long-held beliefs about the relationship between DNA 
methylation and regulatory domains, and also revealed new and unexpected insights. For 
example, DNase hypersensitivity is believed to be a universal signature of active cis-regulatory 
elements and has been shown to be strongly negatively associated with DNA methylation 
(Thurman et al. 2012). Yet we observe a class of shared DHS sites that are fully methylated in 
stem cells and lose methylation in differentiated cells. This suggests, that while permissive DHS 
sites are already set up in embryonic stages, they can still be methylated, until specific 
regulatory events, including histone modifications and ncRNA transcription occur during 
differentiation.  
 
As summarized in Figure 7, we found that one of the primary distinctions between different 
types of iHMRs is the tendency to be either constitutive throughout development or de novo 
demethylated in mature cells. This characteristic separates enhancer-like iHMRs from other 
classes. Our data suggest that these iHMRs are the most cell-type specific and the most 
dynamically regulated during development. Based on our comparison of the different cell-types 
in this study, we may suggest a timeline of enhancer iHMR formation in which three major steps 
are observed. First, DHS are pre-established in the embryonic stem cell, but remain methylated. 
Hematopoietic regulatory elements are partially demethylated during blood cell commitment, a 
process that may be initiated at even earlier stages of differentiation than the HSPC stage 
assessed here. Lastly, lymphoid enhancers become transcribed and completely demethylated 
specifically in B cells, reaching their cell-type specific fully active state (Figure 7). 
 
As most specific iHMRs in adult somatic lymphoid cells are not hypomethylated in the stem cell, 
this would imply that demethylating mechanisms, whether passive or active, are at work in 
differentiating cells. This hypothesis is supported by a recent observation that 
hydroxymethylcytosine marks enhancers in differentiating neural progenitors in mouse 
(Serandour et al. 2012), though it remains to be seen if this association extends to other cell 
types. Alternatively, molecular interactions that protect these regions from maintenance 
methylation may also play a role. Demethylation associated with TF binding could be one such 
mechanism, since it was recently shown that CTCF binding is both necessary and sufficient to 
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create distal regions of low methylation resembling iHMRs (Stadler et al. 2011). Our data 
support this model, since we observe nucleosome displacement and increased frequency of TF 
occupancy at sites that become hypomethylated in lymphoid cells.  
 
The state of DNA methylation at distal regulatory sites also allowed us to infer the activity of 
nearby genes and perhaps even more accurately detect links between iHMR methylation and 
the methylation state at the gene promoter itself. Previously, “active” enhancers were identified 
by histone marks, i.e. H3K4me1 and H3K27ac, which distinguish distal enhancers from proximal 
promoters. Here, we show that iHMRs specifically mark active elements that are linked to both 
pHMR expansion and differential gene expression. Most of these highly active iHMRs also 
harbor TSS for non-coding transcripts. In fact, our data indicate that transcription is a hallmark 
of active iHMRs, and recent evidence suggests a putative functional basis for this phenomenon, 
since disruption of some enhancers, as well as siRNA knock down of eRNAs, interferes with the 
expression of eRNAs and enhancer-regulated genes (Ling et al. 2004, Melo et al. 2013, Wang 
et al. 2011). iHMR transcripts originate from well-defined, position-specific, but generally weak 
promoter sequence elements in the iHMR, in patterns that separate iHMR types and CGIs. 
Close examination of iHMR TSSs reveals conservation of transcriptional sequence signals 
embedded within the iHMR. We observed strand asymmetry (CG skew) in iHMR transcripts, 
reminiscent of features linking transcription to protection from methylation at promoter CGIs  
(Ginno et al. 2012). These characteristics suggest that, in addition to simple TF binding, 
transcription may be involved in establishing or maintaining hypomethylation at dynamic iHMRs. 
Indeed we observed that even low CpG-density intergenic regulatory regions with transcriptional 
activity are strongly hypomethylated. Accordingly, while many lymphocyte-specific iHMRs 
already begin to lose methylation in the early stages of the blood lineage, the complete loss of 
methylation at iHMRs correlates with increased non-coding transcriptional output and enhancer 
activation. Whether or not disruption of these RNAs or their transcription alters enhancer 
methylation states remains to be shown. 
 
iHMRs that show bivalent histone marks in stems cells are typically constitutively 
hypomethylated. Like enhancer iHMRs, their activity appears tightly coordinated with expanded 
pHMRs of nearby genes. We found an unexpected degree of coincidence between pairs of 
bivalent, expanded pHMRs and iHMRs. Previously, “permissive” H3K4me1-marked enhancers 
have been paired with polycomb-repressed promoters (Rada-Iglesias et al. 2011, Taberlay et al. 
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2011), but the extent of bivalently marked iHMRs and their widespread co-occurrence with 
pHMR counterparts had not yet been seen genome-wide.  
 
Patterns of methylation at many iHMRs are conserved in chimpanzee in a manner reflected by 
increased sequence conservation and reduced variation at the epigenetic level within the 
human population. In contrast, a subset of human-specific enhancer-like iHMRs show increased 
methylation variation within the human population. This epigenetic variation may be relevant to 
inter-individual differences in gene regulation and to disease susceptibility (Akhtar-Zaidi et al. 
2012, Toperoff et al. 2012). Loss or gain of TF binding events resulting from sequence 
divergence may account for cross-species differential methylation at constrained elements 
(MacArthur and Brookfield 2004, Prabhakar et al. 2008, Schmidt et al. 2010, Wilson and Odom 
2009). Indeed, only 40% of human B cell specific iHMRs overlap iHMRs of the orthologous cell-
type in chimpanzee compared to constitutive, shared iHMRs of other cell-types. This may signify 
that cell-type specific iHMRs depend on sequence features with a higher turnover rates than 
constitutive hypomethylated regions, including CGIs. In this context, we found that loss of a 
TATA box in enhancer iHMR predicts loss of hypomethylation in chimp, suggesting a role for 
TBP and the transcriptional machinery, in addition to the function of other specific TFs, in the 
establishment of these iHMRs. These comparisons may thus serve to distinguish those 
enhancer iHMRs that fit an “enhanceosome” model, whereby exclusion of a single binding event 
can wipeout enhancer function in one species (possibly by loss of hypomethylation), or a 
“billboard” model in which binding site rearrangements within the enhancer are tolerated as long 
as the sum of TF interaction is constant (Arnosti and Kulkarni 2005, Lusk and Eisen 2010).  
 
Method Summary 
 
GM12878 Methylation data: Lymphoblastoid cell line (LCL) methylomes were generated from 
genomic DNA purchased from Coriell (cat # NA12878) according to methods described 
previously (Molaro et al. 2011). Four flow cell lanes of bisulfite-converted fragment libraries were 
sequenced on the Illumina Hiseq platform to obtain paired-end 100bp read lengths and ~10x 
coverage of the human genome.  
 
Methylation data: Whole-genome bisulfite sequencing data for human B cells, Neutrophils and 
HSPCs were taken from (Hodges et al. 2011, GEO accession number GSE31971), and data for 
H1ESC cells was obtained from (Lister et al. 2009).  
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Methylation data for Chimpanzee-derived hematopoietic cells: Flow Cytometry and DNA 
extraction was performed according to previously described methods (Hodges et al. 2011). 
Briefly, peripheral blood was collected from healthy female donors and pooled. After isolation by 
Ficoll gradient, mononuclear cells were fixed and stained with antibodies against the following 
human cell surface markers (eBiosciences): anti-CD34 conjugated to PE-Cy7, anti-CD38 
conjugated to APC, anti-CD45 conjugated to PE, anti-CD19 conjugated to PE, and anti-CD235a 
(Glycophorin) conjugated to PE. For lineage depletion, either a combination of PE conjugated 
antibodies against CD45, CD19 and CD235a, or a commercially available human hematopoietic 
lineage cocktail was used.  
 
Computational Analysis: Mapping BS-seq reads was performed with methods described by 
Smith et al. (2009) using tools from the RMAP package (Smith et al. 2009). Mapping statistics 
for BS-seq libraries generated herein are provided in Table S1. Hypomethylated regions were 
called for each cell-type using the Hidden Markov Model described in (Hodges et al. 2011). For 
H1ESCs, two replicates were available and only HMRs called in both replicates were used 
(Figure S8A). The methylation level of genomic regions (HMRs, DHS) was computed as the 
mean ratio of converted to unconverted calls at all CpGs in the interval. Expanding promoter 
HMRs were detected as an uninterrupted run of at least 5 significantly differentially methylated 
CpG sites next to a shared HMR (for details on differential methylation calls see (Hodges et al. 
2011)). 
 
We used ChIP-seq or RNA-seq from LCLs (GM12878) as a proxy for B cells. Comparing 
methylation levels at iHMRs, we confirmed that B cell iHMRs are strongly shared with LCLs, 
which hence make a good proxy for B cells (Figure S8B-C). For B cell HMR analysis relying on 
LCL data, only those HMRs with an average methylation level less than 20% in the GM12878 
bisulfite data were used. We did not use HMR calls from the GM12878 methylome itself, since, 
as an immortalized cell line, it contains a number of features differing from primary cells, 
including very large domains of hypomethylation and ‘fuzzy’ HMR boundaries (Figure S8C, and 
S9). 
 
Human genome version 19 and gencode (version 7) gene annotations were used, defining any 
HMR within 250bp of a gene’s 5' end as a TSS HMR, any HMR over 1kb from any gene as 
intergenic and an HMR within a gene that does not overlap any exon as intronic. CpG Island 
calls were obtained from the UCSC genome-browser track “CpG Islands”, based on (Gardiner-
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Garden, 1987) HMRs were considered shared between two cell-types if HMRs called in each 
dataset independently overlap by at least 1 basepair.  
 
Conservation of HMRs between human and chimp: HMRs were called mapping BS-seq data to 
the chimpanzee genome (version panTro3 from the UCSC genome-browser) and lifted over to 
the human genome (hg19) using the UCSC genome browser liftover tool (version 1.28 with the 
‘panTro3ToHg19’ and ‘hg19ToPanTro3’ chains) to assess overlap with human HMRs. Only 
those human HMRs were considered for analysis that had a unique corresponding position in 
the chimpanzee genome (based on liftover to the chimpanzee genome and back resulting in 
only the original position).   
 
All ChIP, MNase and DNase-seq signal tracks were taken from ENCODE (ENCODE Project 
Consortium et al. 2011) (Broad histone ChIP, Duke DNase-seq, Stanford MNase-seq) and are 
scored as fold enrichment over the average genomic read density. TF binding calls are based 
on ENCODE uniform peak calls (SPP) (ENCODE Project Consortium et al. 2011). DNase HS 
sites are based on Duke DNase HS calls in ENCODE. Enhancer and (novel) promoter 
predictions were taken from the ENCODE elements analysis (Yip et al. 2012)  and are based on 
supervised classification of ENCODE histone-modification and TF-binding data. All ENCODE 
datasets are available at http://encodeproject.org/ENCODE/downloads.html 
 
Likely evolutionary conserved positions were determined using the phastCons mammalian 
constraint score (from the UCSC track “Vertebrate Multiz Alignment & Conservation”) with a 
cutoff of 0.9 on the posterior probability of conservation.  
 
Gene expression data was taken from the ENCODE transcriptome group for GM12878 and 
H1ES cells (UCSC ENCODE RNA-seq Track). RNA-seq (UCSC CSHL Long RNA-seq) and 
CAGE (UCSC Riken CAGE) reads in each HMR (based on their 5’ end) were counted and 
normalized (RPKM: reads per kilobase and million mappable reads for long RNA-seq and RPM 
for CAGE). Replicates were pooled and for each HMR the highest value of any RNA type (Poly-
A + or -, Whole Cell, Nuclear or Cytoplasmic) was used. Expression changes are computed as 
log((1 + RPKM1) / (1 + RPKM2)). To avoid confounding effects from host genes, eRNA analysis 
was limited to intergenic iHMRs (> 1kb from any gene). 
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CpG density was computed as the ratio of the observed over expected CpG count based on the 
local CG-density. GC-skew was computed as (G - C) / (G + C). Both were computed in 50 
basepair sliding windows. The sequence-based promoter prediction scores were generated 
using the SVM model implemented in ARTS (Sonnenburg et al. 2006) at single nucleotide 
resolution on both strands of the human genome. The predictions are based on a combination, 
including position-specific core promoter motifs and local sequence features, e.g. k-mer stats. 
For details see (Sonnenburg et al., 2006). The scores are the raw SVM outputs (-5 to 5), with 
positive scores indicating a stronger promoter prediction. TATA-box motifs were called as exact 
matches to 5'-TATAAA-3' within the HMR on either DNA strand.  
 
Clustering of HMRs into chromatin groups was performed using hierarchical clustering (using 
the hclust function of R) with a Manhattan distance and UPGMA linkage on the log-transformed 
ChIP signal. HMRs with any missing data (unmappable regions) or input control signal more 
than 3-fold different from the genomic average were filtered out.  The trees were cut at a branch 
height resulting in 20 groups. Only the major groups, containing at least 10% of the intergenic 
HMRs, were used for further analysis. Clustering of B cell iHMRs was based on chromatin data 
from GM12878 as well as the chromatin state of these sites in H1ESCs, as shown in the 
heatmap (Figure S1E). A comprehensive BED file listing the coordinates of iHMRs and their 
functional annotations are provided in Tables S2 and S3 for H1ESCs and B cells, respectively.  
 
Histone profiles at 'meta-HMRs' were computed by aligning all selected HMRs at their 5' and 3' 
end, evaluating the signal in between in 250 equal-sized steps and taking the (95th percentile) 
trimmed mean at each position. For TSS centered plots the CAGE read density within an HMR 
was smoothed using a 25bp sliding window and the point of highest signal was marked as the 
TSS peak. All boxplots show the 5th, 25th, 50th, 75th and 95th percentiles.  
 
CpG methylation variation in the human population was assessed using targeted bisulfite 
sequencing data from Plongthongkum et al. (manuscript submitted) in whole blood samples of 
44 individuals. Methylation at individual CpGs within HMRs was assessed in 78605 regions 
targeted by padlock probes (BSPP) and compared across individuals. For each CpG site 
targeted by a probe the standard deviation of methylation levels between individuals was 
assessed. Sites with an SD > 0.1 were considered variable. The variability of each HMR was 
then scored as the ratio of probes containing variable CpG sites to total probes overlapping the 
HMR. 
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Data Access 
BS-seq data has been deposited in the SRA (http://www.ncbi.nlm.nih.gov/sra) and GEO 
(http://www.ncbi.nlm.nih.gov/geo/) and is available through the following accession numbers: 
SRP022182 and SRP021118. BSPP data may be accessed with GEO number GSE47614.  
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Figure Legends 
 
Figure 1: Distribution of hypomethylated regions in stem and differentiated cells. 
 (A) Genomic distribution of hypomethylated regions (HMR) in H1ES cells and B cells. Colors in 
each bar indicate whether an HMR is shared between the two cell types, specific to one, or 
shared but expanding, i.e. significantly larger in one cell type than in the other. (B) Overlap 
between iHMRs and DHS in the different cell-types. (C) Most iHMRs contain regions of DNase 
hypersensitivity. The heatmap shows the enrichment of DNase-seq signal at H1ESC iHMRs. 
iHMRs are aligned between the black lines, white points indicate genomic locations not 
mappable with short DNase-seq reads. Rows are sorted by hierarchical clustering. (D) A subset 
of high CpG density DNase HS is hypomethylated. Distribution of average methylation levels for 
DHS in H1ESC split by CpG density (observed / expected; O/E). (E) Hypomethylated DHS are 
marked by histone modifications. Log fold enrichment over genomic background for H3K4me2 
at intergenic H1ESC DHS with high (> 0.4 O/E) CpG density is shown. (F) Hypomethylated DHS 
have higher sequence conservation. The fraction of positions with PhastCons scores over 0.9 in 
intergenic DHS depending on methylation state is shown.  
 
Figure 2: Hypomethylated regions mark different classes of active genomic regulatory 
elements. 
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 (A) Diverse chromatin states at H1 iHMRs. Heatmap showing the chromatin state within 
iHMRs. Each column represents one iHMR, sorted by hierarchical clustering, grouped into 4 
main clusters. The top lines indicate overlap of the HMR with functional element predictions 
from ENCODE, CpG Islands, the iHMR location (intergenic or intronic), and whether it is shared 
between H1ESCs and B cells. (B) Average chromatin mark profile in H1ESC iHMRs of the 4 
different clusters defined in (A). HMRs are aligned between the black lines, and the fold-
enrichment signals are averaged across all iHMRs at each relative position. Bold lines highlight 
the histone marks that distinguish each cluster (C) Barplots show, for each of the defined 
classes, the fraction of iHMRs occupied by factors associated with different types of elements 
and chromatin states.  
 
Figure 3: Coordinated changes in pHMRs, iHMRs and histone marks occur at cell-type 
specifically regulated genes. 
 (A) Differential hypomethylation at expanding promoter HMRs. B cell pHMRs are aligned 
between the black lines and color denotes the change in methylation level between H1ESCs 
and B cells at each position. (B) As above, differential H3K4me2 ChIP-seq signal in H1ESCs is 
displayed for the same sites. Color denotes the fold change in H3K4me2 enrichment between 
H1ESCs and LCLs (C) Enhancer HMRs are enriched near expanding promoter HMRs. 
Cumulative density plot showing the distances between expanded or constant pHMRs and 
enhancer or CTCF iHMRs. (D) Genes with both expanding pHMRs and nearby cell-type specific 
iHMRs are up-regulated. Median fold expression change (CAGE signal) between LCLs and 
H1ESCs for genes grouped by the distance to the closest B cell specific iHMR and by significant 
expansion of their promoter HMR. (E) A subset of expanded promoter HMRs are silenced and 
marked with H3K27me3 in stem cells. Genes with an H1ESC specific expanded promoter HMR 
are split by their expression levels (at 1 CAGE RPM) and fold enrichment for H3K27me3 at the 
promoter in H1ES cells is shown. (F) Bivalent Promoters have nearby bivalently marked iHMRs. 
Scatterplot with H3K27me3 signal at pairs of pHMRs and nearby (<25kb) iHMRs. 
 
Figure 4: Resolution of bivalent iHMRs during differentiation and stepwise, de-novo 
hypomethylation at transcribed enhancer-like iHMRs 
 (A) Bivalent iHMRs are resolved to active or silenced chromatin states during differentiation. 
Heatmap showing the LCL chromatin profile at iHMRs with a bivalent chromatin signature in 
H1ESCs. Sidebar colors indicates whether the HMR remains hypomethylated in B cells (green) 
or becomes fully methylated (black). (B) Example locus surrounding ANXA2R, a gene 
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expressed in lymphocytes and bone marrow, illustrating the coordinated resolution of the H1ES 
cell bivalent chromatin state in B cells / LCL.  ENCODE regulation and transcription tracks are 
shown along with chromatin states modeled by ChromHMM (Ernst et al. 2011) in H1ES and 
GM12878 cells. Transcription tracks are presented in log scale. (C) Transcribed, active 
enhancer-like iHMRs in B cells are fully methylated in H1ESCs and show intermediate states in 
other blood cell-types. Differences in methylation level between other cell-types and B cell 
iHMRs are shown. (D) Only B cell iHMRs with eRNA (> 0.1 RPKM) show strong enrichment for 
chromatin marks suggesting an active regulatory state.  
 
Figure 5: iHMRs produce different classes of transcripts from specific transcription start 
sites 
Different types of RNAs arise from iHMRs classes. Boxplots represent the distribution of values 
(5th to 95th percentile) for each iHMR class, compared to annotated lincRNAs and mRNAs. 
Enhancer iHMR transcripts are less expressed and less poly-adenylated, while bivalent HMRs 
make low abundance Poly-A RNAs. Promoter-like, but not enhancer-like iHMRs contain strong 
promoter sequence signals. (A) Expression level, (B) Nuclear localization,.(C) Polyadenylation 
levels, (D) Genomic-sequence based promoter prediction scores (ARTS). (E-H) eRNA TSS 
positions match specific sequence and chromatin features. (E) Fraction of positions covered 
with RNA-seq (transcript body) and CAGE tags (TSS). (F) Specific positional arrangement of 
histone modifications and DNase hypersensitivity around the eRNA TSS. (G) CpG density is 
symmetric around the TSS, but GC-skew (strand bias of 'G' vs. 'C') occurs specifically in the 
direction of transcription. (H) ARTS Genomic-sequence based TSS prediction scores peak at 
the experimentally defined eRNA TSS in the sense direction. (I) Transcription is linked with 
hypomethylation at intergenic DHSs. Methylation levels at DHS with or without transcription. (J) 
Presence of the TATA motif at DHS is linked with hypomethylation. Methylation levels at DHS 
with and without an exact TATA motif match. (K) The TATA-motif predicts transcription of 
enhancer-like iHMRs. The barplot depicts the fraction of expressed (CAGE RPM > 0.1) and 
silent iHMRs in different clusters that contain an exact TATAAA match. 
 
Figure 6. iHMRs are conserved in methylation state and sequence, and are enriched for 
human population variation in methylation levels. 
(A) Cell-type specific hypomethylation is conserved between human and chimp. Overlap 
between human B cell specific or shared HMRs with HMRs in different chimpanzee cell types. 
(B) Intergenic HMRs shared between human and chimp are also more conserved at the 
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sequence level. (C) Enhancer-like iHMRs are more variable between human and chimp. 
Barplots show the percentage of B cell iHMRs of different classes that overlap a chimp B cell 
iHMR. (D) Conservation of the TATA-motif at enhancer-like iHMRs predicts conservation of 
hypomethylation. Barplots show the percentage of human iHMRs (containing the TATA motif) 
shared with chimp for (left) transcribed, enhancer-like iHMRs and (right) CTCF iHMRs, 
depending on whether the TATA motif is conserved in chimp. (E) Methylation is more variable at 
enhancer-like iHMRs in the human population. Barplots show the fraction of probed loci in 
different HMR classes at which methylation levels vary significantly between whole blood 
samples from individuals (see methods). (F) iHMRs that are conserved with chimp are also less 
variable in methylation level between human individuals. 
 
Figure 7. Model of iHMR behavior at a B cell-specifically expressed gene. 
Shared DHS sites are pre-established in the embryonic stem cell. Hypomethylation at the CpG 
Island gene promoter (right) and at a CTCF iHMR (left) is constant during development. The 
enhancer-like iHMR (center) is fully methylated in H1ESC. In blood-specified progenitors 
(HSPCs), it becomes partially methylated, but remains inactive, i.e. lacks H3K4 methylation and 
RNA transcription. In the B cell state, where the gene is expressed, the promoter HMR expands 
beyond the core CGI region and the iHMR becomes fully hypomethylated. The enhancer-like 
iHMR displays an active enhancer chromatin state (H3K4me1, H3K27ac). It is bound by TBP 
and RNA Pol II at specific sequence elements (including the TATA-box), which initiate eRNA 
transcription within the iHMR. 
 
Supplementary Files and Figures 
 
Figures 
S1. Summary of HMR properties 
(a) Fraction of HMRs overlapping CpG Islands (UCSC) 
(b) CpG Density (observed / expected) at HMRs 
(c) Number of H1ESC iHMRs in different clusters and their status in B cells. 
(d) Overlap of iHMRs with functional element predictions from ENCODE in H1ESCs. 
(e) Metaplots of MNase-seq read density from LCLs around iHMRs. 
(f) Heatmap showing the chromatin state within B cell iHMRs based on LCL data, 
compared to their state in H1ESCs. Each row represents one iHMR, sorted by 
hierarchical clustering.  
 
S2. Example pHMR vs. intergenic iHMR  
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UCSC Genome Browser tracks display methylation profiles across a lymphoid specific 
expanded pHMR (A) and iHMR (B). Methylation frequencies, ranging from 0 to 1, of 
unique reads covering individual CpG sites are shown. Horizontal bars show identified 
hypomethylated regions (HMRs). ENCODE histone tracks are also shown. 
 
S3. Expanding Promoter HMRs 
Features of expanding promoter HMRs. Order matching Figure 3A) 
(a) CpG Density (observed / expected) in 50bp windows normalized to the maximum per 
row 
(b) CAGE tags in H1ESC cells 
(c) H3K4me2 enrichment over input in H1ESC cells 
(d) Most, but not all genes with expanding promoter HMRs are up-regulated. Boxplots 
representing the range of expression fold changes (CAGE signal; 5th to 95th percentile) 
for genes with or without an expanding promoter HMR in H1ES cells vs. differentiated 
LCLs are shown. 
(e) Bivalent chromatin state at expanded but transcriptionally silent promoter HMRs in H1ES 
cells. H1 hypomethylation expands over a larger region compared to the B cell state and 
is matched by H3K27me3 enrichment, while the core region of the HMR is shared and 
marked by H3K4me2. 
 
S4. Examples of shared intergenic iHMRs in H1ESC and LCLs that acquire H3K27me3 in 
LCLs. 
 
S5. Methylation levels and Transcription at iHMRs in the blood lineage 
(a) Methylation changes (difference in average CpG methylation level) at iHMRs between 
different blood cells and B cells shown for constitutive (shared with H1ESCs) and blood 
specific iHMRs. 
(b) Transcription marks bivalent iHMRs resolved to an active state. Chromatin profile in 
LCLs of iHMRs, which were bivalent in H1ESCs, depending on their transcriptional state 
(CAGE > 0.1RPM) in LCLs. 
(c) Genes near iHMRs resolved to an active state are upregulated. Gene expression fold 
change between LCLs and H1ESCs (CAGE RPM) for promoters near H1 bivalent 
iHMRs (1 – 25 kb), grouped by transcription at the iHMR. 
(d) Chromatin state at promoter HMRs from (c). 
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S6. Chromatin state and transcription at DHS 
(a) The Methylation state of DHS is only weakly related to the DNase-seq signal level. 
Average methylation level and DNase tag score for all intergenic DHS with a CpG 
density greater than  0.4 Observed / Expected. 
(b) Some pre-existing DHS become hypomethylated during differentiation. Change in 
methylation levels at intergenic non-CTCF DHS shared between H1ESCs and B cells. 
(c) Activation of shared DHS with variable methylation. Heatmap showing the chromatin 
state of DHS sites shared between H1ESC and B cells with B cell-specific iHMRs 
(methylation level in H1ESCs over 70%). 
(d) TBP binding predicts hypomethylation at DHS. Fraction of DHS overlapping iHMRs 
depending on DNase HS score and presence of a TBP ChiP-seq peak. 
 
S7. TBP and TATA boxes at eRNA 
(a) The TATA-motif is enriched upstream of the eRNA TSS. Coverage by CAGE tags 
around TATA motif occurrences in iHMRs. 
(b) TFs are enriched at eRNA TSS. Profile of Tbp and Taf1 ChIP-seq signal in H1ESCs 
around CAGE peaks in enhancer-like iHMRs. 
(c) The TATA sequence at iHMRs is conserved. Average PhastCons score at TATA 
motifs (MEME hits for motif MA0108.2) around (-100bp to +25bp) TSS in enhancer 
HMRs. 
Zoom-in of c). 
S8. Reproducibility of H1 HMRs, LCL/B cell HMR overlap 
(a) Fraction of HMRs that are reproducible between H1ESC bisulfite-seq replicates 
(b) Methylation level differences between B cells and LCLs (GM12878) at different HMR 
types. 
(c) B cell-specific iHMRs are hypomethylated in LCLs (GM12878), but not in Neutrophils. 
Heatmaps showing methylation levels per CpG site for areas around B cell intergenic 
non-CTCF iHMRs. iHMRs are aligned based on their B cell boundaries between the 
black lines. 
 
S9.  Comparing features of primary B cell, LCL, and H1ESC methylomes. 
(a) Violin plots show the distribution of global methylation levels across all CpG sites with 
>9x coverage for B cells, LCLs and H1ESCs.  
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(b) Pearson correlations of methylation levels between LCLs and other cell-types are given 
for either all CpG sites, or only CpG sites overlapping B cell HMRs. 
(c) Scatterplots show high concordance between LCLs and B cells for CpG methylation 
levels within B cell specific HMRs. High-density scatter plots with color transparency 
show individual CpG methylation levels (each dot) that intersect B cell HMRs for H1ESC 
vs. B cell (C), H1ESC vs. LCL (D) and B cell vs. LCL (E). Only CpG sites with >9x 
coverage were included.   
 
Table S1. Mapping, Methylation and HMR Statistics 
 
Table S2. H1ESC iHMRs and Cluster Annotations 
BED file of iHMRs with cluster assignment (in column 4): 
 2: Promoter-like, 3: CTCF, 4: Bivalent, 5: Enhancer-like 
 
Table S3. B cell iHMRs and Cluster Annotaions 
BED file of iHMRs with cluster assignment (in column 4): 
 2: Promoter-like, 3: Enhancer-like, 4: CTCF, 5: silent, 6: silent Promoter-like 
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